Working… Menu

A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03886831
Recruitment Status : Recruiting
First Posted : March 22, 2019
Last Update Posted : May 3, 2021
Information provided by (Responsible Party):
Prelude Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 11, 2021
Estimated Study Completion Date : August 11, 2022